FTC Reports Significant Growth in Flavored E-Cigarette Sales

Oct.12.2022

US FTC report shows flavored e-cigarette sales have significantly increased in US market.

The US Federal Trade Commission (FTC) has recently released a report on the sales and advertising of e-cigarettes, revealing a significant increase in flavored e-cigarette sales in the US market.

Since 1967, the US Federal Trade Commission has been reporting on the sales of tobacco products every year. Last year, the organization expanded its research scope to include electronic cigarettes and published its first report on the subject.

Translated from "Tobacco Industry News

#North America #United States #Traditional tobacco #Legislation #E-cigarette #E-cigarettes and Tobacco #Flavored tobacco and nicotine products #Report #E-cigarettes with Flavors

This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Eleventh session of the Conference of the Parties (COP11) to the WHO FCTC

Eleventh session of the Conference of the Parties (COP11) to the WHO FCTC

Cigar Sense Inc. Announces Research in Cigars to Connect Consumer Expectations, Experiences, and Authentic Brand Storytelling

Independent research initiative highlights consumer truth as the new driver of loyalty and meaningful differentiation.

Belarus Increases e-cigarette tax by 20% and Reinstates Tax on heated tobacco

Belarus Increases e-cigarette tax by 20% and Reinstates Tax on heated tobacco

Belarus government plans to raise tobacco tax by 12% and e-cigarette tax by 20%, aiming to regulate all smoking devices.

Oct.21 by 2FIRSTS.ai

Product | Dual-flavor, 30,000-puff SKE 2-in-1 launches across multiple UK distributor platforms.

Product | Dual-flavor, 30,000-puff SKE 2-in-1 launches across multiple UK distributor platforms.

E-cigarette brand SKE has listed its “30K Pro Max” bundle across multiple UK e-commerce platforms. The 2-in-1 device features dual flavors with a twist-to-switch design, draw activation, and mesh heating, with a claimed total of up to 30,000 puffs. Across several channels, single-unit pricing ranges from about £8.99 to £10.99.

Oct.24 by 2FIRSTS.ai

WHO's First Global E-Cigarette Data: Over 100 Million Users, Youth Risk 9 Times Higher

WHO's First Global E-Cigarette Data: Over 100 Million Users, Youth Risk 9 Times Higher

The WHO's first global estimate on October 6 showed over 100 million people use e-cigarettes, including at least 15 million adolescents (aged 13–15). The report warned that in reporting countries, children are nine times more likely to vape than adults.

Oct.07 by 2FIRSTS.ai

Exclusive Interview | What’s Changing in Cigars? A Data Firm’s Perspective on the Industry’s Turning Point

Exclusive Interview | What’s Changing in Cigars? A Data Firm’s Perspective on the Industry’s Turning Point

As regulations tighten, consumer habits evolve, and new nicotine products reshape the market, the cigar industry is undergoing a quiet but profound transformation. In this exclusive interview, 2Firsts speaks with Cigar Sense — a data-driven sensory analysis firm — to explore what’s really changing in cigars, and what it means for manufacturers, retailers, and smokers around the world.

Smoore International's subsidiary, Transcend Biopharma, has its ANDA accepted by the FDA, potentially granting it 180 days of market exclusivity

Smoore International's subsidiary, Transcend Biopharma, has its ANDA accepted by the FDA, potentially granting it 180 days of market exclusivity

Smoore International announced that the U.S. FDA has accepted the Abbreviated New Drug Application (ANDA) for its Breo® Ellipta® 100/25 generic drug, submitted by its wholly-owned subsidiary, Transpire Bio. Transpire Bio stated that if approved, it is expected to receive 180 days of market exclusivity. In the United States, Breo® Ellipta® is already approved for the maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD).

Sep.25 by 2FIRSTS.ai

Related Topics

News

Related Read

Cigar Sense Inc. Announces Research in Cigars to Connect Consumer Expectations, Experiences, and Authentic Brand Storytelling

Belarus Increases e-cigarette tax by 20% and Reinstates Tax on heated tobacco

Belarus Increases e-cigarette tax by 20% and Reinstates Tax on heated tobacco

Product | Dual-flavor, 30,000-puff SKE 2-in-1 launches across multiple UK distributor platforms.

Product | Dual-flavor, 30,000-puff SKE 2-in-1 launches across multiple UK distributor platforms.

WHO's First Global E-Cigarette Data: Over 100 Million Users, Youth Risk 9 Times Higher

WHO's First Global E-Cigarette Data: Over 100 Million Users, Youth Risk 9 Times Higher

Exclusive Interview | What’s Changing in Cigars? A Data Firm’s Perspective on the Industry’s Turning Point

Exclusive Interview | What’s Changing in Cigars? A Data Firm’s Perspective on the Industry’s Turning Point

Smoore International's subsidiary, Transcend Biopharma, has its ANDA accepted by the FDA, potentially granting it 180 days of market exclusivity

Smoore International's subsidiary, Transcend Biopharma, has its ANDA accepted by the FDA, potentially granting it 180 days of market exclusivity

FOLLOW US ON SOCIAL MEDIA

Contact: info@2firsts.com

Stay up to date.

Submit your email to receive weekly newsletter on the most relevant news of the e-cigarette industry.

sign up

© 2025 Shenzhen 2FIRSTS Technology Co.,Ltd. All Right Reserved.

2FIRSTS is only accessible to industry practitioners, researchers, media and other professionals. Access by minors is prohibited.

This website provides services to users outside the Chinese mainland. For Chinese mainland users, please visit https://cn.2firsts.com

English

English

中文